Adaptive Biotechnologies Corp Stock Price Patterns
| ADPT Stock | USD 18.50 0.13 0.71% |
Momentum 57
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.16) | EPS Estimate Current Year (0.49) | EPS Estimate Next Year (0.58) | Wall Street Target Price 20.1429 | EPS Estimate Current Quarter (0.14) |
Using Adaptive Biotechnologies hype-based prediction, you can estimate the value of Adaptive Biotechnologies Corp from the perspective of Adaptive Biotechnologies response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Adaptive Biotechnologies using Adaptive Biotechnologies' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Adaptive using crowd psychology based on the activity and movement of Adaptive Biotechnologies' stock price.
Adaptive Biotechnologies Short Interest
An investor who is long Adaptive Biotechnologies may also wish to track short interest. As short interest increases, investors should be becoming more worried about Adaptive Biotechnologies and may potentially protect profits, hedge Adaptive Biotechnologies with its derivative instruments, or be ready for some potential downside.
200 Day MA 13.2615 | Short Percent 0.0756 | Short Ratio 4.15 | Shares Short Prior Month 8.8 M | 50 Day MA 17.073 |
Adaptive Biotechnologies Hype to Price Pattern
Investor biases related to Adaptive Biotechnologies' public news can be used to forecast risks associated with an investment in Adaptive. The trend in average sentiment can be used to explain how an investor holding Adaptive can time the market purely based on public headlines and social activities around Adaptive Biotechnologies Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Adaptive Biotechnologies' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Adaptive Biotechnologies.
Adaptive Biotechnologies Implied Volatility | 1.12 |
Adaptive Biotechnologies' implied volatility exposes the market's sentiment of Adaptive Biotechnologies Corp stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Adaptive Biotechnologies' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Adaptive Biotechnologies stock will not fluctuate a lot when Adaptive Biotechnologies' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Adaptive Biotechnologies to buy its stock at a price that has no basis in reality. In that case, they are not buying Adaptive because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Adaptive Biotechnologies after-hype prediction price | USD 18.51 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Adaptive contract
Based on the Rule 16, the options market is currently suggesting that Adaptive Biotechnologies Corp will have an average daily up or down price movement of about 0.07% per day over the life of the 2026-04-17 option contract. With Adaptive Biotechnologies trading at USD 18.5, that is roughly USD 0.013 . If you think that the market is fully incorporating Adaptive Biotechnologies' daily price movement you should consider acquiring Adaptive Biotechnologies Corp options at the current volatility level of 1.12%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Adaptive Biotechnologies Basic Forecasting Models to cross-verify your projections. Adaptive Biotechnologies After-Hype Price Density Analysis
As far as predicting the price of Adaptive Biotechnologies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Adaptive Biotechnologies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Adaptive Biotechnologies, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Adaptive Biotechnologies Estimiated After-Hype Price Volatility
In the context of predicting Adaptive Biotechnologies' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Adaptive Biotechnologies' historical news coverage. Adaptive Biotechnologies' after-hype downside and upside margins for the prediction period are 13.52 and 23.50, respectively. We have considered Adaptive Biotechnologies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Adaptive Biotechnologies is somewhat reliable at this time. Analysis and calculation of next after-hype price of Adaptive Biotechnologies is based on 3 months time horizon.
Adaptive Biotechnologies Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Adaptive Biotechnologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Adaptive Biotechnologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Adaptive Biotechnologies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.23 | 4.99 | 0.01 | 0.16 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
18.50 | 18.51 | 0.05 |
|
Adaptive Biotechnologies Hype Timeline
Adaptive Biotechnologies is presently traded for 18.50. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of 0.16. Adaptive is projected to increase in value after the next headline, with the price projected to jump to 18.51 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is projected to be 0.05%, whereas the daily expected return is presently at 0.23%. The volatility of related hype on Adaptive Biotechnologies is about 719.02%, with the expected price after the next announcement by competition of 18.66. The company reported the previous year's revenue of 178.96 M. Net Loss for the year was (159.59 M) with profit before overhead, payroll, taxes, and interest of 164.49 M. Given the investment horizon of 90 days the next projected press release will be in about 10 days. Check out Adaptive Biotechnologies Basic Forecasting Models to cross-verify your projections.Adaptive Biotechnologies Related Hype Analysis
Having access to credible news sources related to Adaptive Biotechnologies' direct competition is more important than ever and may enhance your ability to predict Adaptive Biotechnologies' future price movements. Getting to know how Adaptive Biotechnologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Adaptive Biotechnologies may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CDTX | Cidara Therapeutics | (0.39) | 5 per month | 1.30 | 0.13 | 5.93 | (4.54) | 105.72 | |
| MLYS | Mineralys Therapeutics Common | (1.40) | 11 per month | 0.00 | (0.09) | 5.87 | (6.28) | 24.81 | |
| SRRK | Scholar Rock Holding | 1.56 | 11 per month | 2.42 | 0.15 | 5.92 | (4.21) | 31.68 | |
| LEGN | Legend Biotech Corp | (1.30) | 12 per month | 0.00 | (0.28) | 3.83 | (6.84) | 19.65 | |
| IDYA | Ideaya Biosciences | 0.21 | 10 per month | 2.03 | 0.06 | 4.86 | (3.68) | 15.68 | |
| IRON | Disc Medicine | 3.05 | 11 per month | 0.00 | (0.05) | 4.42 | (4.35) | 16.19 | |
| CPRX | Catalyst Pharmaceuticals | 0.03 | 11 per month | 1.52 | 0.11 | 3.00 | (3.08) | 10.89 | |
| BEAM | Beam Therapeutics | 4.19 | 11 per month | 3.57 | 0.03 | 8.12 | (6.28) | 31.78 | |
| ZLAB | Zai Lab | (0.21) | 9 per month | 0.00 | (0.27) | 4.56 | (4.03) | 10.32 | |
| TARS | Tarsus Pharmaceuticals | 1.20 | 13 per month | 2.06 | (0.02) | 3.78 | (3.76) | 12.48 |
Adaptive Biotechnologies Additional Predictive Modules
Most predictive techniques to examine Adaptive price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Adaptive using various technical indicators. When you analyze Adaptive charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Adaptive Biotechnologies Predictive Indicators
The successful prediction of Adaptive Biotechnologies stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Adaptive Biotechnologies Corp, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Adaptive Biotechnologies based on analysis of Adaptive Biotechnologies hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Adaptive Biotechnologies's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Adaptive Biotechnologies's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 9.79 | 9.92 | 8.93 | 7.27 | Days Of Inventory On Hand | 69.8 | 42.74 | 49.15 | 46.69 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Adaptive Stock Analysis
When running Adaptive Biotechnologies' price analysis, check to measure Adaptive Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adaptive Biotechnologies is operating at the current time. Most of Adaptive Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Adaptive Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adaptive Biotechnologies' price. Additionally, you may evaluate how the addition of Adaptive Biotechnologies to your portfolios can decrease your overall portfolio volatility.